Penumbra (PEN) Other Operating Expenses (2018 - 2024)
Penumbra's (PEN) quarterly Other Operating Expenses came in at $76.9 million in Q2 2024, up 322.43% quarter-over-quarter from $18.2 million in Q3 2023.
Analysis
Penumbra (PEN) Other Operating Expenses (2018 - 2024) Analysis & Trends
Penumbra (PEN) has reported Other Operating Expenses for 3 consecutive years, with $76.9 million the latest figure, recorded in Q2 2024.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $76.9 million in Q2 2024; TTM through Mar 2025 was $76.9 million, a 322.43% increase from a year earlier, with the FY2024 full-year figure at $76.9 million, up 322.43% from the prior year.
- Other Operating Expenses was $76.9 million for Q2 2024 at Penumbra, up from $18.2 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $76.9 million in Q2 2024 and troughed at $18.2 million in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn |
| 3 | Medtronic | 118.18 Bn | 109.36 Bn | 6.34 Bn |
| 4 | Stryker | 104.54 Bn | 101.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.34 Bn | 65.80 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.64 Bn | 45.39 Bn | 1.35 Bn |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn |
| 8 | Dexcom | 32.20 Bn | 30.25 Bn | 830.00 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn |
| 10 | Penumbra | 12.58 Bn | 11.92 Bn | 264.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 76.95 Mn |
| Sep 30, 2023 | 18.22 Mn |
| Sep 30, 2018 | 30.84 Mn |